Endovascular laser-tissue interactions and biological responses in relation to endovenous laser therapy

Lasers in Medical Science

Volumn 29, Issue 2, 2014, Pages 405-422

  Heger, Michal ^a   Van Golen, Rowan F ^a   Broekgaarden, Mans ^a   Van Den Bos, Renate R ^b   Neumann, H A Martino ^b   Van Gulik, Thomas M ^a   Van Gemert, Martin J C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines and chemokines; Damage associated molecular patterns; Endovenous laser ablation; Fibrosis; Great saphenous vein; Inflammation; Innate immune response; Phagocytosis; Tissue remodeling; Varicose veins; Venous thrombus organization

Indexed keywords

ANTICOAGULANT AGENT; COLLAGEN; FIBROBLAST GROWTH FACTOR; HEAT SHOCK PROTEIN; HEPARANASE; INTERCELLULAR ADHESION MOLECULE 1; PHOSPHATIDYLSERINE; PLATELET DERIVED GROWTH FACTOR; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DEEP VEIN THROMBOSIS; ENDOVENOUS LASER THERAPY; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; INFLAMMATORY CELL; INTRACELLULAR SIGNALING; LASER COAGULATION; LASER-INDUCED THROMBOSIS; LEG VARICOSIS; LOW LEVEL LASER THERAPY; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; THERAPY EFFECT; THERMAL INJURY; THROMBOCYTE ACTIVATION; TISSUE INTERACTION; TREATMENT DURATION; VEIN WALL; ADVERSE EFFECTS; CHEMOTAXIS; CYTOSOL; ENDOVASCULAR SURGERY; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SCAR; SIGNAL TRANSDUCTION; THROMBOSIS; VARICOSE VEINS; VASCULAR ENDOTHELIUM;

CHEMOTAXIS; CICATRIX; COLLAGEN; CYTOSOL; ENDOTHELIUM, VASCULAR; ENDOVASCULAR PROCEDURES; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HUMANS; INFLAMMATION; LASER THERAPY; PHOSPHATIDYLSERINES; PLATELET ACTIVATION; SIGNAL TRANSDUCTION; THROMBOSIS; VARICOSE VEINS;

EID: 84897083156     PISSN: 02688921     EISSN: 1435604X     Source Type: Journal    
DOI: 10.1007/s10103-013-1490-3     Document Type: Review

References (210)

1. Nijsten T, van den Bos RR, Goldman MP, Kockaert MA, Proebstle TM, Rabe E, Sadick NS, Weiss RA, Neumann MH (2009) Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol 60:110-119
2. van den Bos RR, Kockaert MA, Neumann HA, Nijsten T (2008) Technical review of endovenous laser therapy for varicose veins. Eur J Vasc Endovasc Surg 35:88-95 (Pubitemid 350235232)
3. van den Bos RR, Neumann M, De Roos KP, Nijsten T (2009) Endovenous laser ablation-induced complications: review of the literature and new cases. Dermatol Surg 35:1206-1214
4. Myers K, Fris R, Jolley D (2006) Treatment of varicose veins by endovenous laser therapy: assessment of results by ultrasound surveillance. Med J Aust 185:199-202 (Pubitemid 44322781)
5. Fan CM, Rox-Anderson R (2008) Endovenous laser ablation: mechanism of action. Phlebology 23:206-213
6. Vuylsteke ME, Mordon SR (2012) Endovenous laser ablation: a review of mechanisms of action. Ann Vasc Surg 26:424-433
7. Schmedt CG, Sroka R, Steckmeier S, Meissner OA, Babaryka G, Hunger K, Ruppert V, Sadeghi-Azandaryani M, Steckmeier BM (2006) Investigation on radiofrequency and laser (980 nm) effects after endoluminal treatment of saphenous vein insufficiency in an ex-vivo model. Eur J Vasc Endovasc Surg 32:318-325 (Pubitemid 44204117)
8. van den Bos RR, Kockaert MA, Martino Neumann HA, Bremmer RH, Nijsten T, van Gemert MJ (2009) Heat conduction from the exceedingly hot fiber tip contributes to the endovenous laser ablation of varicose veins. Lasers Med Sci 24:247-251
9. Disselhoff BC, Rem AI, Verdaasdonk RM, Kinderen DJ, Moll FL (2008) Endovenous laser ablation: an experimental study on the mechanism of action. Phlebology 23:69-76
10. Proebstle TM, Sandhofer M, Kargl A, Gul D, Rother W, Knop J, Lehr HA (2002) Thermal damage of the inner vein wall during endovenous laser treatment: key role of energy absorption by intravascular blood. Dermatol Surg 28:596-600 (Pubitemid 34816041)
11. Proebstle TM, Lehr HA, Kargl A, Espinola-Klein C, Rother W, Bethge S, Knop J (2002) Endovenous treatment of the greater saphenous vein with a 940-nm diode laser: thrombotic occlusion after endoluminal thermal damage by laser-generated steam bubbles. J Vasc Surg 35:729-736
12. Theivacumar NS, Dellagrammaticas D, Beale RJ, Mavor AI, Gough MJ (2008) Factors influencing the effectiveness of endovenous laser ablation (EVLA) in the treatment of great saphenous vein reflux. Eur J Vasc Endovasc Surg 35:119-123 (Pubitemid 350235236)
13. Heger M (2013) Thrombosis versus thermal coagulum formation as a result of endovenous laser therapy: biochemistry versus photophysics, Phlebology
14. Bush RG, Shamma HN, Hammond K (2008) Histological changes occurring after endoluminal ablation with two diode lasers (940 and 1319 nm) from acute changes to 4 months. Lasers Surg Med 40:676-679
15. Proebstle TM, Gul D, Lehr HA, Kargl A, Knop J (2003) Infrequent early recanalization of greater saphenous vein after endovenous laser treatment. J Vasc Surg 38:511-516 (Pubitemid 41123217)
16. Vuylsteke M, Van DJ, Roelens J, De BT, Mordon S (2009) Endovenous laser treatment: a morphological study in an animal model. Phlebology 24:166-175
17. Vuylsteke M, Van DJ, Roelens J, De BT, Mordon S, Fourneau I (2010) Intraluminal fibre-tip centring can improve endovenous laser ablation: a histological study. Eur J Vasc Endovasc Surg 40:110-116
18. Oh CK, Jung DS, Jang HS, Kwon KS (2003) Endovenous laser surgery of the incompetent greater saphenous vein with a 980-nm diode laser. Dermatol Surg 29:1135-1140
19. Proebstle TM, Moehler T, Herdemann S (2006) Reduced recanalization rates of the great saphenous vein after endovenous laser treatment with increased energy dosing: definition of a threshold for the endovenous fluence equivalent. J Vasc Surg 44:834-839 (Pubitemid 44441762)
20. Corcos L, Dini S, De AD, Marangoni O, Ferlaino E, Procacci T, Spina T, Dini M (2005) The immediate effects of endovenous diode 808-nm laser in the greater saphenous vein: morphologic study and clinical implications. J Vasc Surg 41:1018-1024 (Pubitemid 40813032)
21. der Kinderen DJ, Disselhoff BC, Koten JW, de Bruin PC, Seldenrijk CA, Moll FL (2009) Histopathologic studies of the below-the-knee great saphenous vein after endovenous laser ablation. Dermatol Surg 35:1985-1988
22. Vuylsteke ME, Martinelli T, Van DJ, Roelens J, Mordon S, Fourneau I (2011) Endovenous laser ablation: the role of intraluminal blood. Eur J Vasc Endovasc Surg 42:120-126
23. Samouillan V, Dandurand J, Lacabanne C, Stella A, Gargiulo M, Degani A, Gandaglia A, Spina M (2012) Analysis of the molecular mobility of collagen and elastin in safe, atheromatous and aneurysmal aortas. Pathol Biol (Paris) 60:58-65
24. Gorisch W, Boergen KP (1982) Heat-induced contraction of blood vessels. Lasers Surg Med 2:1-13 (Pubitemid 12062788)
25. Lin MG, Yang TL, Chiang CT, Kao HC, Lee JN, Lo W, Jee SH, Chen YF, Dong CY, Lin SJ (2006) Evaluation of dermal thermal damage by multiphoton autofluorescence and second-harmonicgeneration microscopy, J Biomed Opt 11:064006
26. Weiss RA (2002) Comparison of endovenous radiofrequency versus 810 nm diode laser occlusion of large veins in an animal model. Dermatol Surg 28:56-61
27. Viarengo LM, Poterio-Filho J, Poterio GM, Menezes FH, Meirelles GV(2007) Endovenous laser treatment for varicose veins in patients with active ulcers: measurement of intravenous and perivenous temperatures during the procedure. Dermatol Surg 33:1234-1242
28. Mahdavian DB, van der Veer WM, van Egmond M, Niessen FB, Beelen RH (2011) Macrophages in skin injury and repair. Immunobiology 216:753-762
29. McDonald B, Pittman K, Menezes GB, Hirota SA, Slaba I, Waterhouse CC, Beck PL, Muruve DA, Kubes P (2010) Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330:362-366
30. Kumar V, Sharma A (2010) Neutrophils: Cinderella of innate immune system. Int Immunopharmacol 10:1325-1334
31. Heger M, Beek JF, Moldovan NI, van der Horst CM, van Gemert MJ (2005) Towards optimization of selective photothermolysis: prothrombotic pharmaceutical agents as potential adjuvants in laser treatment of port wine stains. A theoretical study. Thromb Haemost 93:242-256 (Pubitemid 40253728)
32. Heger M, Salles II, Bezemer R, Cloos MA, Mordon SR, Begu S, Deckmyn H, Beek JF (2011) Laser-induced primary and secondary hemostasis dynamics and mechanisms in relation to selective photothermolysis of port wine stains. J Dermatol Sci 63:139-147
33. Newton PM, Watson JA, Wolowacz RG, Wood EJ (2004) Macrophages restrain contraction of an in vitro wound healing model. Inflammation 28:207-214 (Pubitemid 41449420)
34. Miller FJ (2001) Adventitial fibroblasts: backstage journeymen. Arterioscler Thromb Vasc Biol 21:722-723
35. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A (1996) Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94:1655-1664 (Pubitemid 26320272)
36. Li G, Chen SJ, Oparil S, Chen YF, Thompson JA (2000) Direct in vivo evidence demonstrating neointimal migration of adventitial fibroblasts after balloon injury of rat carotid arteries. Circulation 101:1362-1365 (Pubitemid 30169855)
37. Chen GY, Nunez G (2010) Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10:826-837
38. Sugimoto N, Shido O, Matsuzaki K, Ohno-Shosaku T, Hitomi Y, Tanaka M, Sawaki T, Fujita Y, Kawanami T, Masaki Y, Okazaki T, Nakamura H, Koizumi S, Yachie A, Umehara H (2012) Cellular heat acclimation regulates cell growth, cell morphology, mitogen-activated protein kinase activation, and expression of aquaporins in mouse fibroblast cells. Cell Physiol Biochem 30:450-457
39. Jurivich DA, Chung J, Blenis J (1991) Heat shock induces two distinct S6 protein kinase activities in quiescent mammalian fibroblasts. J Cell Physiol 148:252-259 (Pubitemid 21910148)
40. Zalewski A, Shi Y (1997) Vascular myofibroblasts. Lessons from coronary repair and remodeling. Arterioscler Thromb Vasc Biol 17: 417-422 (Pubitemid 27133129)
41. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FH, Simonet L, Wilcox JN (1996) Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 93:2178-2187 (Pubitemid 26187108)
42. Shi Y, O'Brien JE Jr, Ala-Kokko L, Chung W, Mannion JD, Zalewski A (1997) Origin of extracellular matrix synthesis during coronary repair. Circulation 95:997-1006 (Pubitemid 27091546)
43. Labropoulos N, Bhatti A, Leon L, Borge M, Rodriguez H, Kalman P (2006) Neovascularization after great saphenous vein ablation. Eur J Vasc Endovasc Surg 31:219-222 (Pubitemid 43078952)
44. Marsh P, Price BA, Holdstock J, Harrison C, Whiteley MS (2010) Deep vein thrombosis (DVT) after venous thermoablation techniques: rates of endovenous heat-induced thrombosis (EHIT) and classical DVTafter radiofrequency and endovenous laser ablation in a single centre. Eur J Vasc Endovasc Surg 40:521-527
45. Black JF, Barton JK (2004) Chemical and structural changes in blood undergoing laser photocoagulation. Photochem Photobiol 80:89-97
46. Black JF, Wade N, Barton JK (2005) Mechanistic comparison of blood undergoing laser photocoagulation at 532 and 1,064 nm. Lasers Surg Med 36:155-165 (Pubitemid 40315489)
47. Heger M, Beek J, Stenback K, Faber D, van Gemert M, Ince C (2005) Darkfield orthogonal polarized spectral imaging for studying endovenous laser-tissue interactions in vivo - a preliminary study. Opt Express 13:702-715 (Pubitemid 40334870)
48. Heger M, Bezemer R, Huertas-Perez JF, Dekker H, Beek JF (2010) Endovenous laser-tissue interactions redefined: shining light on novel windows of therapeutic opportunity beyond selective photothermolysis. Photomed Laser Surg 28:569-572
49. Bezemer R, Heger M, van den Wijngaard JP, Mordon SR, van Gemert MJ, Beek JF (2007) Laser-induced (endo)vascular photothermal effects studied by combined brightfield and fluorescence microscopy in hamster dorsal skin fold venules. Opt Express 15:8493-8506 (Pubitemid 47112460)
50. Barton JK, Popok D, Black JF (2001) Thermal analysis of blood undergoing laser photocoagulation. IEEE J Sel Top Quantum Electron 7:936-943 (Pubitemid 34191812)
51. Geering B, Stoeckle C, Conus S, Simon HU (2013) Living and dying for inflammation: neutrophils, eosinophils, basophils. Trends Immunol 34:398-409
52. Zong WX, Thompson CB (2006) Necrotic death as a cell fate. Genes Dev 20:1-15
53. Brouckaert G, Kalai M, Krysko DV, Saelens X, Vercammen D, Ndlovu MN, Haegeman G, D'Herde K, Vandenabeele P (2004) Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol Biol Cell 15:1089-1100 (Pubitemid 38316218)
54. Sakallioglu AE, Basaran O, Karakayali H, Ozdemir BH, Yucel M, Arat Z, Haberal M (2006) Interactions of systemic immune response and local wound healing in different burn depths: an experimental study on rats. J Burn Care Res 27:357-366 (Pubitemid 43970304)
55. von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Kollnberger M, Byrne RA, Laitinen I, Walch A, Brill A, Pfeiler S, Manukyan D, Braun S, Lange P, Riegger J, Ware J, Eckart A, Haidari S, Rudelius M, Schulz C, Echtler K, Brinkmann V, Schwaiger M, Preissner KT, Wagner DD, Mackman N, Engelmann B, Massberg S (2012) Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 209:819-835
56. Seizer P, Gawaz M, May AE (2008) Platelet-monocyte interactions - a dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr Med Chem 15:1976-1980
57. Stadelmann WK, Digenis AG, Tobin GR (1998) Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 176:26S-38S (Pubitemid 28460655)
58. Gear AR, Camerini D (2003) Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10:335-350 (Pubitemid 39004260)
59. Sakamoto H, Firkin FC, Chesterman CN (1984) Stimulation of leukocyte phagocytic activity by the platelet release reaction. Pathology 16:126-130 (Pubitemid 14130865)
60. de Bruijne-Admiraal LG, Modderman PW, Von dem Borne AE, Sonnenberg A (1992) P-selectin mediates Ca(2+)-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood 80:134-142
61. Otterdal K, Smith C, Oie E, Pedersen TM, Yndestad A, Stang E, Endresen K, Solum NO, Aukrust P, Damas JK (2006) Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood 108:928-935 (Pubitemid 44154627)
62. Heemskerk JW, Bevers EM, Lindhout T (2002) Platelet activation and blood coagulation. Thromb Haemost 88:186-193 (Pubitemid 34873696)
63. Camire RM, Kalafatis M, Simioni P, Girolami A, Tracy PB (1998) Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood 91:2818-2829 (Pubitemid 28227532)
64. Bondanza A, Sabbadini MG, Pellegatta F, Zimmermann VS, Tincani A, Balestrieri G, Manfredi AA, Rovere P (2000) Anti-beta2 glycoprotein I antibodies prevent the de-activation of platelets and sustain their phagocytic clearance. J Autoimmun 15:469-477
65. Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH (1991) Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 77:2641-2648
66. Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ (1991) Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 266:17261-17268 (Pubitemid 21907934)
67. Hoffman M, Monroe DM, Roberts HR (1992) Coagulation factor IXa binding to activated platelets and platelet-derived microparticles: a flow cytometric study. Thromb Haemost 68:74-78
68. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ (1988) Complement proteins C5b-9 cause release ofmembrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263: 18205-18212 (Pubitemid 19005097)
69. Pasquet JM, Toti F, Nurden AT, Dachary-Prigent J (1996) Procoagulant activity and active calpain in platelet-derived microparticles. Thromb Res 82:509-522 (Pubitemid 26233236)
70. Barry OP, Pratico D, Lawson JA, FitzGerald GA (1997) Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 99:2118-2127 (Pubitemid 27203768)
71. Jy W, Mao WW, Horstman L, Tao J, Ahn YS (1995) Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 21:217-231 (Pubitemid 26083518)
72. Krysko DV, D'Herde K, Vandenabeele P (2006) Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 11:1709-1726 (Pubitemid 44371047)
73. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216
74. Krysko O, De RL, Cornelissen M (2004) Phosphatidylserine exposure during early primary necrosis (oncosis) in JB6 cells as evidenced by immunogold labeling technique. Apoptosis 9:495-500 (Pubitemid 38987586)
75. Hirt UA, Leist M (2003) Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ 10:1156-1164 (Pubitemid 37258581)
76. Jones AL, Poon IK, Hulett MD, Parish CR (2005) Histidine-rich glycoprotein specifically binds to necrotic cells via its aminoterminal domain and facilitates necrotic cell phagocytosis. J Biol Chem 280:35733-35741 (Pubitemid 41532766)
77. Hespanhol MR, Mantovani B (2002) Phagocytosis bymacrophages mediated by receptors for denatured proteins - dependence on tyrosine protein kinases. Braz J Med Biol Res 35:383-389 (Pubitemid 34285513)
78. Davis GE (1992) The Mac-1 and p150,95 beta 2 integrins bind denatured proteins to mediate leukocyte cell-substrate adhesion. Exp Cell Res 200:242-252
79. Sewell RF, Brenchley PE, Mallick NP (1989) Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate. Biochem J 264:777-783 (Pubitemid 20023449)
80. Ishai-Michaeli R, Eldor A, Vlodavsky I (1990) Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix. Cell Regul 1:833-842
81. Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, Lider O, Naparstek Y, Cohen IR, Fuks Z (1992) Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12:112-127
82. Ihrcke NS, Parker W, Reissner KJ, Platt JL (1998) Regulation of platelet heparanase during inflammation: role of pH and proteinases. J Cell Physiol 175:255-267 (Pubitemid 28198205)
83. Reiland J, Sanderson RD, Waguespack M, Barker SA, Long R, Carson DD, Marchetti D (2004) Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion. J Biol Chem 279:8047-8055 (Pubitemid 38294693)
84. Bame KJ (2001) Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans. Glycobiology 11:91R-98R
85. Geyer G, Linss W, Stibenz D (1977) Adsorbed proteins mask negatively charged sites of the erythrocyte glycocalyx. Acta Histochem 60:312-316 (Pubitemid 8247829)
86. Okumura T, Jamieson GA (1976) Platelet glycocalicin. I. Orientation of glycoproteins of the human platelet surface, J. Biol Chem 251:5944-5949
87. Czarnowska E, Karwatowska-Prokopczuk E (1995) Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals. Basic Res Cardiol 90:357-364
88. van Golen RF, van Gulik TM, Heger M (2012) Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radic Biol Med 52:1382-1402
89. Kumar V, Abbas AK, Fausto N, Mitchell R (2007) Robbins basic pathology. Saunders, Philadelphia
90. Martin P, Leibovich SJ (2005) Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 15:599-607 (Pubitemid 41619424)
91. Mordon S, Wassmer B, Servell P, Desmyttere J, Grard C, Stalnikiewicz G (2009) Is a vein filled with blood a good model for studying endovenous laser ablation? Lasers Surg Med 41:543-544
92. Heere-Ress E, Veensalu M, Wacheck V, Tzaneva S, Kittler H, Kapiotis S, Wolzt M, Bohler K (2011) Does endovenous laser ablation induce endothelial damage at the saphenofemoral junction? Dermatol Surg 37:1456-1463
93. Martinelli I, Bucciarelli P, Mannucci PM (2010) Thrombotic risk factors: basic pathophysiology. Crit Care Med 38:S3-S9
94. Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman DK, McKenzie SE, Cooley BC, Poncz M, Newman PJ (2013) Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood 121:1858-1867
95. Schulz C, Engelmann B, Massberg S (2013) Crossroads of coagulation and innate immunity: the case of deep vein thrombosis. J Thromb Haemost 11(Suppl 1):233-241
96. Hamburger SA, McEver RP (1990) GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 75:550-554 (Pubitemid 20069190)
97. Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B (1989) PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59:305-312 (Pubitemid 19264376)
98. Coeffier E, Delautier D, Le Couedic JP, Chignard M, Denizot Y, Benveniste J (1990) Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation. J Leukoc Biol 47:234-243 (Pubitemid 20097662)
99. Yan Z, Zhang J, Holt JC, Stewart GJ, Niewiarowski S, Poncz M (1994) Structural requirements of platelet chemokines for neutrophil activation. Blood 84:2329-2339 (Pubitemid 24296396)
100. Futosi K, Fodor S, Mocsai A (2013) Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int Immunopharmacol 17:638-650
101. Chertov O, Ueda H, Xu LL, Tani K, Murphy WJ, Wang JM, Howard OM, Sayers TJ, Oppenheim JJ (1997) Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 186:739-747 (Pubitemid 27381538)
102. Kasama T, Strieter RM, Standiford TJ, Burdick MD, Kunkel SL (1993) Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. J Exp Med 178:63-72 (Pubitemid 23173243)
103. Kasama T, Strieter RM, Lukacs NW, Burdick MD, Kunkel SL (1994) Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 152:3559-3569 (Pubitemid 24098053)
104. Lee A, Whyte MK, Haslett C (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol 54:283-288 (Pubitemid 23317694)
105. Hume DA, Ross IL, Himes SR, Sasmono RT, Wells CA, Ravasi T (2002) The mononuclear phagocyte system revisited. J Leukoc Biol 72:621-627 (Pubitemid 36277831)
106. DiPietro LA (1995)Wound healing: the role of the macrophage and other immune cells. Shock 4:233-240
107. Dole VS, Bergmeier W, Mitchell HA, Eichenberger SC, Wagner DD (2005) Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. Blood 106:2334-2339 (Pubitemid 41510804)
108. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594 (Pubitemid 28157601)
109. Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, Vestweber D, Wagner DD (2000) P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J ExpMed 191:1413-1422 (Pubitemid 30227127)
110. Boehme MW, Galle P, Stremmel W (2002) Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 107:340-349 (Pubitemid 35356954)
111. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR (1996) In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 93:11877-11882 (Pubitemid 26347217)
112. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104:1533-1537 (Pubitemid 32917347)
113. Dole VS, Bergmeier W, Patten IS, Hirahashi J, Mayadas TN, Wagner DD (2007) PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets. Thromb Haemost 98:806-812 (Pubitemid 47555073)
114. Xu T, Zhang L, Geng ZH, Wang HB, Wang JT, Chen M, Geng JG (2007) P-selectin cross-links PSGL-1 and enhances neutrophil adhesion to fibrinogen and ICAM-1 in a Src kinase-dependent, but GPCR-independent mechanism. Cell Adhes Migr 1:115-123
115. Ma YQ, Plow EF, Geng JG (2004) P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. Blood 104:2549-2556 (Pubitemid 39331860)
116. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, Celi A, Croce K, Furie BC, Furie B (2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197:1585-1598 (Pubitemid 36682554)
117. Abou-Saleh H, Theoret JF, Yacoub D, Merhi Y (2005) Neutrophil P-selectin-glycoprotein-ligand-1 binding to platelet P-selectin enhances metalloproteinase 2 secretion and platelet-neutrophil aggregation. Thromb Haemost 94:1230-1235 (Pubitemid 41819621)
118. Anrather D, Millan MT, Palmetshofer A, Robson SC, Geczy C, Ritchie AJ, Bach FH, Ewenstein BM (1997) Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF. J Immunol 159:5620-5628 (Pubitemid 127470093)
119. Szaba FM, Smiley ST (2002) Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo. Blood 99:1053-1059 (Pubitemid 34525570)
120. Senden NH, Jeunhomme TM, Heemskerk JW, Wagenvoord R, van't Veer C, Hemker HC, Buurman WA (1998) Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol 161:4318-4324 (Pubitemid 28469016)
121. Qi J, Goralnick S, Kreutzer DL (1997) Fibrin regulation of interleukin-8 gene expression in human vascular endothelial cells. Blood 90:3595-3602 (Pubitemid 27473429)
122. Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meinl C, May A, Schomig A (1997) Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 95:2387-2394 (Pubitemid 27224733)
123. Henke PK, Wakefield TW (2009) Thrombus resolution and vein wall injury: dependence on chemokines and leukocytes. Thromb Res 123(Suppl 4):S72-S78
124. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD, Schmidt R, Kunkel SL, Greenfield LJ (1995) Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 15:258-268
125. Wojcik BM, Wrobleski SK, Hawley AE, Wakefield TW, Myers DD Jr, Diaz JA (2011) Interleukin-6: a potential target for post-thrombotic syndrome. Ann Vasc Surg 25:229-239
126. Henke PK, Pearce CG, Moaveni DM, Moore AJ, Lynch EM, Longo C, Varma M, Dewyer NA, Deatrick KB, Upchurch GR Jr, Wakefield TW, Hogaboam C, Kunkel SL (2006) Targeted deletion of CCR2 impairs deep vein thombosis resolution in a mouse model. J Immunol 177:3388-3397 (Pubitemid 44277859)
127. Henke PK, Varga A, De S, Deatrick CB, Eliason J, Arenberg DA, Sukheepod P, Thanaporn P, Kunkel SL, Upchurch GR Jr, Wakefield TW(2004) Deep vein thrombosis resolution ismodulated bymonocyte CXCR2-mediated activity in a mouse model. Arterioscler Thromb Vasc Biol 24:1130-1137 (Pubitemid 38737842)
128. Gawaz M, Page S, Massberg S, Nothdurfter C, Weber M, Fisher C, Ungerer M, Brand K (2002) Transient platelet interaction induces MCP-1 production by endothelial cells via I kappa B kinase complex activation. Thromb Haemost 88:307-314 (Pubitemid 34873714)
129. Wenzel UO, Fouqueray B, Grandaliano G, Kim YS, Karamitsos C, Valente AJ, Abboud HE (1995) Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. Circ Res 77:503-509
130. von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, Proudfoot AE, Hackeng TM, Weber C (2005) Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105:924-930 (Pubitemid 40170856)
131. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176:587-592
132. Weyrich AS, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA (1995) Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 95:2297-2303
133. Leu HJ, Feigl W, Susani M, Odermatt B (1988) Differentiation of mononuclear blood cells into macrophages, fibroblasts and endothelial cells in thrombus organization. Exp Cell Biol 56:201-210 (Pubitemid 18260945)
134. Varma MR, Varga AJ, Knipp BS, Sukheepod P, Upchurch GR, Kunkel SL, Wakefield TW, Henke PK (2003) Neutropenia impairs venous thrombosis resolution in the rat. J Vasc Surg 38:1090-1098 (Pubitemid 37409647)
135. Moir E, Booth NA, Bennett B, Robbie LA (2001) Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism. Br J Haematol 113:72-80 (Pubitemid 32423305)
136. Singh I, Burnand KG, Collins M, Luttun A, Collen D, Boelhouwer B, Smith A (2003) Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells. Circulation 107:869-875 (Pubitemid 36241046)
137. Henke PK, Varma MR, Deatrick KB, Dewyer NA, Lynch EM, Moore AJ, Dubay DA, Sukheepod P, Pearce CG, Upchurch GR Jr, Kunkel SL, Franz MG, Wakefield TW (2006) Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization. Thromb Haemost 95:272-281
138. Stief TW, Aab A, Heimburger N (1988) Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor. Thromb Res 49:581-589
139. Wu K, Urano T, Ihara H, Takada Y, Fujie M, Shikimori M, Hashimoto K, Takada A (1995) The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis. Blood 86:1056-1061
140. Athens JW, Haab OP, Raab SO, Mauer AM, Ashenbrucker H, Cartwright GE, Wintrobe MM (1961) Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest 40:989-995
141. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA (1976) Neutrophil kinetics in man. J Clin Invest 58:705-715
142. Peters AM, Roddie ME, Danpure HJ, Osman S, Zacharopoulos GP, George P, Stuttle AW, Lavender JP (1988) 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes. Nucl Med Commun 9:449-463
143. McMillan R, Scott JL (1968) Leukocyte labeling with 51-chromium. I. Technique and results in normal subjects. Blood 32:738-754
144. Jitkaew S, Witasp E, Zhang S, Kagan VE, Fadeel B (2009) Induction of caspase- and reactive oxygen species-independent phosphatidylserine externalization in primary human neutrophils: role in macrophage recognition and engulfment. J Leukoc Biol 85:427-437
145. Webster NL, Crowe SM (2006) Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J Leukoc Biol 80:1052-1066 (Pubitemid 44646311)
146. Hiller O, Lichte A, Oberpichler A, Kocourek A, Tschesche H (2000) Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of
147. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95:365-377 (Pubitemid 28507325)
148. Makowski GS, Ramsby ML (1998) Binding of latent matrix metalloproteinase 9 to fibrin: activation via a plasmin-dependent pathway. Inflammation 22:287-305 (Pubitemid 28234157)
149. Brancato SK, Albina JE (2011) Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol 178:19-25
150. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH (1987) Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 165:251-256 (Pubitemid 17223686)
151. Koyama N, Koshikawa T, Morisaki N, Saito Y, Yoshida S (1990) Bifunctional effects of transforming growth factor-beta onmigration of cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 169:725-729 (Pubitemid 20216168)
152. Massague J (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6:597-641
153. Verrecchia F, Chu ML, Mauviel A (2001) Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276:17058-17062
154. Deatrick KB, Obi A, Luke CE, Elfline MA, Sood V, Upchurch GR, Jr, Jaffer F, Wakefield TW, Henke PK (2013) Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT, Thromb Res 132:360-366
155. Grainger DJ, Wakefield L, Bethell HW, Farndale RW, Metcalfe JC (1995) Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1:932-937
156. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556-7562 (Pubitemid 32525636)
157. Garcia-de-Alba C, Becerril C, Ruiz V, Gonzalez Y, Reyes S, Garcia-Alvarez J, Selman M, Pardo A (2010) Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am J Respir Crit Care Med 182:1144-1152
158. Tonar Z, Kural T Jr, Kochova P, Nedorost L, Witter K (2012) Vasa vasorum quantification in human varicose great and small saphenous veins. Ann Anat 194:473-481
159. Jain RK, Au P, Tam J, Duda DG, Fukumura D (2005) Engineering vascularized tissue. Nat Biotechnol 23:821-823 (Pubitemid 43093121)
160. Rouwkema J, Rivron NC, van Blitterswijk CA (2008) Vascularization in tissue engineering. Trends Biotechnol 26:434-441
161. San Biagio PL, Martorana V, Emanuele A, Vaiana SM, Manno M, Bulone D, Palma-Vittorelli MB, Palma MU (1999) Interacting processes in protein coagulation. Proteins 37:116-120 (Pubitemid 29408924)
162. Otsuka M, Goto K, Tsuchiya S, Aramaki Y (2005) Phosphatidylserine- specific receptor contributes to TGF-beta production in macrophages through a MAP kinase, ERK. Biol Pharm Bull 28:1707-1710 (Pubitemid 41324137)
163. Yu M, Wang HC, Ding AH, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26:174-179 (Pubitemid 44162504)
164. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8:487-496 (Pubitemid 46605917)
165. Quintana FJ, Cohen IR (2005) Heat shock proteins as endogenous adjuvants in sterile and septic inflammation. J Immunol 175:2777-2782 (Pubitemid 41170492)
166. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, Wagner H (2001) Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276:31332-31339 (Pubitemid 37385004)
167. Basu S, Binder RJ, Ramalingam T, Srivastava PK (2001) CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303-313 (Pubitemid 32289294)
168. D'Souza CA, Rush SJ, Brown IR (1998) Effect of hyperthermia on the transcription rate of heat-shock genes in the rabbit cerebellum and retina assayed by nuclear run-ons. J Neurosci Res 52:538-548 (Pubitemid 28252735)
169. Madersbacher S, Grobl M, Kramer G, Dirnhofer S, Steiner GE, Marberger M (1998) Regulation of heat shock protein 27 expression of prostatic cells in response to heat treatment. Prostate 37:174-181 (Pubitemid 28487900)
170. Bush KT, Goldberg AL, Nigam SK (1997) Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem 272:9086-9092 (Pubitemid 27154911)
171. Eigenbrod T, Park JH, Harder J, Iwakura Y, Nunez G (2008) Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J Immunol 181:8194-8198
172. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13:851-856 (Pubitemid 47038190)
173. Libby P, Ordovas JM, Birinyi LK, Auger KR, Dinarello CA (1986) Inducible interleukin-1 gene-expression in human vascular smoothmuscle cells. J Clin Investig 78:1432-1438 (Pubitemid 17219503)
174. Moussion C, Ortega N, Girard JP (2008) The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? Plos One 3:e3331
175. Kakkar R, Hei H, Dobner S, Lee RT (2012) Interleukin 33 as a mechanically responsive cytokine secreted by living cells. J Biol Chem 287:6941-6948
176. Alves JC, Sonego F, Souto FO, Freitas A, Verri WA, Auxiliadora-Martins M, Basile A, McKenzie AN, Xu DM, Cunha FQ, Liew FY (2010) Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 16:708-U113
177. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195 (Pubitemid 34773774)
178. Basu S, Binder RJ, Suto R, Anderson K, Srivastava PK (2000) Necrotic but not apoptiotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF kappa B pathway. Cell Stress Chaperones 5:373
179. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228-232 (Pubitemid 43372102)
180. Warner SJ, Libby P (1989) Human vascular smooth-muscle cells - target for and source of tumor necrosis factor. J Immunol 142:100-109 (Pubitemid 19034728)
181. Jackson A, Friedman S, Zhan X, Engleka KA, Forough R, Maciag T (1992) Heat-shock induces the release of fibroblast growth factor-I from Nih-3T3 cells. Proc Natl Acad Sci U S A 89:10691-10695
182. Chotani MA, Payson RA, Winkles JA, Chiu IM (1995) human fibroblast growth factor-1 gene-expression in vascular smooth-muscle cells is modulated via an alternate promoter in response to serum and phorbol ester. Nucleic Acids Res 23:434-441
183. Santos-Ocampo S, Colvin JS, Chellaiah A, Ornitz DM (1996) Expression and biological activity of mouse fibroblast growth factor-9. J Biol Chem 271:1726-1731 (Pubitemid 26029604)
184. Loo BM, Darwish K, Vainikka S, Saarikettu J, Vihko P, Hermonen J, Goldman A, Alitalo K, Jalkanen M (2000) Production and characterization of the extracellular domain of recombinant human fibroblast growth factor receptor 4. Int J Biochem Cell Biol 32:489-497 (Pubitemid 30154030)
185. Kan M, Wu XC, Wang F, McKeehan WL (1999) Specificity for fibroblast growth factors determined by heparan sulfate in a binary complex with the receptor kinase. J Biol Chem 274:15947-15952
186. Li GH, Oparil S, Kelpke SS, Chen YF, Thompson JA (2002) Fibroblast growth factor receptor-1 signaling induces osteopontin expression and vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro. Circulation 106:854-859
187. Ding Q, Gladson CL, Guidry CR, Santoro SA, Dickeson SK, Shin JT, Thompson JA (2000) Extracellular FGF-1 inhibits cytoskeletal organization and promotes fibroblast motility. Growth Factors 18:93-107
188. Udayakumar TS, Nagle RB, Bowden GT (2004) Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line. Prostate 58:66-75 (Pubitemid 38057990)
189. Grieb TA, Burgess WH (2000) The mitogenic activity of fibroblast growth factor-1 correlates with its internalization and limited proteolytic processing. J Cell Physiol 184:171-182 (Pubitemid 30432308)
190. Lin YZ, Yao SY, Hawiger J (1996) Role of the nuclear localization sequence in fibroblast growth factor-1-stimulated mitogenic pathways. J Biol Chem 271:5305-5308
191. Proebstle TM, Krummenauer F, Gul D, Knop J (2004) Nonocclusion and early reopening of the great saphenous vein after endovenous laser treatment is fluence dependent. Dermatol Surg 30:174-178 (Pubitemid 38314006)
192. Vuylsteke M, Liekens K, Moons P, Mordon S (2008) Endovenous laser treatment of saphenous vein reflux: how much energy do we need to prevent recanalizations? Vasc Endovasc Surg 42:141-149 (Pubitemid 351550918)
193. Wagenseil JE, Mecham RP (2009) Vascular extracellularmatrix and arterial mechanics. Physiol Rev 89:957-989
194. Di WH, Ratsep MT, Chapman A, Boyd R (2010) Adventitial fibroblasts in vascular structure and function: the role of oxidative stress and beyond. Can J Physiol Pharmacol 88:177-186
195. Gill SE, Parks WC (2008) Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 40:1334-1347
196. Diegelmann RF, Evans MC (2004)Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9:283-289 (Pubitemid 38925460)
197. Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69:11-25
198. Riikonen T, Westermarck J, Koivisto L, Broberg A, Kahari VM, Heino J (1995) Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression. J Biol Chem 270:13548-13552
199. Lillie MA, Chalmers GW, Gosline JM (1994) The effects of heating on the mechanical properties of arterial elastin. Connect Tissue Res 31:23-35 (Pubitemid 2159631)
200. Svensson G, Linse S, Mani K (2009) Chemical and thermal unfolding of glypican-1: protective effect of heparan sulfate against heat-induced irreversible aggregation. Biochemistry 48:9994-10004
201. Li C, Xu Q (2000) Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal 12:435-445
202. Yamamoto K, Yamamoto M (1994) Cell adhesion receptors for native and denatured type I collagens and fibronectin in rabbit arterial smooth muscle cells in culture. Exp Cell Res 214:258-263 (Pubitemid 24302400)
203. Yamamoto M, Yamato M, Aoyagi M, Yamamoto K (1995) Identification of integrins involved in cell adhesion to native and denatured type I collagens and the phenotypic transition of rabbit arterial smooth muscle cells. Exp Cell Res 219:249-256
204. Herz DB, Aitken K, Bagli DJ (2003) Collagen directly stimulates bladder smooth muscle cell growth in vitro: regulation by extracellular regulated mitogen activated protein kinase. J Urol 170:2072-2076 (Pubitemid 37255011)
205. Chung CH, Lin KT, Chang CH, Peng HC, Huang TF (2009) The integrin alpha2beta1 agonist, aggretin, promotes proliferation and migration of VSMC through NF-kB translocation and PDGF production. Br J Pharmacol 156:846-856
206. Cabodi S, Di Stefano P, Leal MDC, Tinnirello A, Bisaro B, Morello V, Damiano L, Aramu S, Repetto D, Tornillo G, Defilippi P (2010) Integrins and signal transduction. In: Becchetti A, Arcangeli A (eds) Integrins and ion channels: molecular complexes and signaling, vol 674. Springer, Berlin, pp 43-54
207. Marx SO, Totary-Jain H, Marks AR (2011) Vascular smoothmuscle cell proliferation in restenosis. Circ Cardiovasc Interv 4:104-111
208. Gowen BB, Borg TK, Ghaffar A, Mayer EP (2000) Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors. Matrix Biol 19:61-71 (Pubitemid 30109396)
209. Hsu HY, Chiu SL, Wen MH, Chen KY, Hua KF (2001) Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J Biol Chem 276:28719-28730
210. Abraham LC, Dice JF, Lee K, Kaplan DL (2007) Phagocytosis and remodeling of collagen matrices. Exp Cell Res 313:1045-1055 (Pubitemid 46273449)